← back to search

Xiaoying Chen

Capital Normal University · AU
Area of research
Epidemiology · Neurology
Research interest
Research interests include Acute Ischemic Stroke Management, Intracerebral and Subarachnoid Hemorrhage Research, Traumatic Brain Injury and Neurovascular Disturbances, and Stroke Rehabilitation and Recovery.
h-index
32
citations
6,303
works
262
NIH funding
primary concept
Medicine
email

Recent publications

Interaction of brain imaging features and effects of intensive blood pressure lowering after endovascular treatment for acute ischaemic stroke: the pre-specified secondary analyses of ENCHANTED2/MT trial
EClinicalMedicine 2025cited by 5position: middledoi
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial
Nature Communications 2025cited by 5position: middledoi
Comparative analysis of gut microbiota in free range and house fed yaks from Linzhou County
Scientific Reports 2025cited by 3position: middledoi
Twenty‐Four‐Hour Post‐Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study
Journal of the American Heart Association 2024cited by 22position: middledoi
Traditional Chinese Medicine for the Treatment of Acute Intracerebral Haemorrhage: A Multicentre, Randomised, Placebo-Controlled, Double-Blind, Clinical Trial
SSRN Electronic Journal 2024cited by 0position: middledoi
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
The Lancet 2023cited by 347position: middledoi
Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective study
Photodiagnosis and Photodynamic Therapy 2023cited by 27position: middledoi
Optimum Baseline Clinical Severity Scale Cut Points for Prognosticating Intracerebral Hemorrhage: INTERACT Studies
Stroke 2023cited by 22position: middledoi
Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells
Pharmaceutical Biology 2023cited by 5position: middledoi
Effects of Intensive Blood Pressure Lowering on Cerebral Ischaemia in Thrombolysed Patients: Insights from the Enchanted Trial
SSRN Electronic Journal 2023cited by 0position: middledoi
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
The Lancet 2022cited by 241position: middledoi
The injuries of spleen and intestinal immune system induced by 2-Gy <sup>60</sup>Co γ-ray whole-body irradiation
Figshare 2022cited by 0position: middledoi
Cardio-protective effect of tetrahydrocurcumin, the primary hydrogenated metabolite of curcumin in vivo and in vitro: Induction of apoptosis and autophagy via PI3K/AKT/mTOR pathways
European Journal of Pharmacology 2021cited by 39position: firstdoi
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome
Stroke 2020cited by 37position: middledoi
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
The Lancet 2019cited by 268position: middledoi
Anti-melanogenesis properties of condensed tannins from <i>Vigna angularis</i> seeds with potent antioxidant and DNA damage protection activities
Food & Function 2018cited by 71position: middledoi
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
New England Journal of Medicine 2016cited by 434position: middledoi
Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities
International Journal of COPD 2016cited by 52position: firstdoi
Rationale, Design, and Progress of the ENhanced Control of Hypertension ANd Thrombolysis Stroke Study (ENCHANTED) Trial: An International Multicenter 2 × 2 Quasi-Factorial Randomized Controlled Trial of Low- vs. Standard-Dose rt-PA and Early Intensive vs. Guideline-Recommended Blood Pressure Lowering in Patients with Acute Ischaemic Stroke Eligible for Thrombolysis Treatment
International Journal of Stroke 2015cited by 90position: middledoi
Gastroprotective effect of andrographolide sodium bisulfite against indomethacin-induced gastric ulceration in rats
International Immunopharmacology 2015cited by 69position: middledoi
White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial
Journal of the Neurological Sciences 2015cited by 54position: middledoi
Application of comprehensive nursing path for patients with chronic pelvic inflammatory disease
Zhonghua xiandai huli zazhi 2014cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Craig S. Anderson · Fudan University4 papers (2015–2024)Candice Delcourt · UNSW Sydney4 papers (2015–2024)John Chalmers · Amrita Vishwa Vidyapeetham4 papers (2015–2024)Hisatomi Arima · Nishijin Hospital4 papers (2015–2024)Danni Zheng · The University of Sydney3 papers (2020–2024)Xia Wang · Anhui Medical University3 papers (2020–2024)Thompson Robinson · University of Leicester3 papers (2020–2024)Lili Song · State Key Laboratory of Medical Neurobiology3 papers (2020–2024)Richard I. Lindley · The University of Sydney3 papers (2020–2024)Yongjun Cao · Nantong University2 papers (2023–2024)Shoujiang You · Soochow University2 papers (2023–2024)Menglu Ouyang · Tongji University2 papers (2023–2024)Jianhui Xie · Guangzhou University of Chinese Medicine2 papers (2015–2021)Ziren Su · Guangzhou University of Chinese Medicine2 papers (2015–2021)Chun‐Feng Liu · Soochow University2 papers (2023–2024)Shujun Liu · Shandong University1 papers (2021–2021)Shujing Zhang · Dalian Medical University1 papers (2022–2022) · 1 papers (2014–2014)Xie Zhang · Guangzhou University of Chinese Medicine1 papers (2015–2015)Yushan Gao · Beijing University of Chinese Medicine1 papers (2022–2022)